Clinical Research Studies

Hope for Patients

Our research offers hope for current patients and opportunities to make a difference for future patients. We explore every area of cardiovascular care. Ask your doctor about active MHIF studies that match your treatment needs.

Benefits of Research

Be More Active Icon

Be More Active

Take a more active role in your own health care.

Lock Icon

Potential to Unlock More Options

You may gain access to investigational treatments and medications.

Contribution Icon

Make a Contribution

Help find a new and better way to treat people with your condition.

Promise for Providers

MHIF leads more than 230 studies annually, promising you and your patients access to cutting-edge care. Our High Enroll app makes it even easier to connect with this clinical advantage. By downloading the app and establishing a free account, providers can:

  • Follow currently-enrolling MHIF studies
  • Learn study details and inclusion/exclusion criteria
  • Identify and refer patients
  • Receive updates and new study notifications
  • Communicate with research coordinators


Our app puts all this information at your fingertips, whether you’re on- or off-line.

As one of the leading nonprofit cardiovascular research and education institutions, MHIF is proud to be the first in Minnesota to bring this innovative app to providers. Join us in raising awareness for life-saving research.

Download High Enroll and establish your account today.

Download on Google Play
Download on Apple Store


MHIF on High Enroll app
Give the Gift of Hope
4 photos of families smiling

The Minneapolis Heart Institute Foundation® (MHIF) strives to create a world without heart and vascular disease. To achieve this bold vision, we are dedicated to improving the cardiovascular health of individuals and communities through innovative research and education.

Thanks to the generosity of donors like you, we can continue this life-saving work. Please make a gift to support the area of greatest need.

Research Milestone: FDA approves device used as alternative to open-heart

blue background
Triclip team

We are honored to celebrate the culmination of years of research that has resulted in new technologies for patients! In the few last weeks, we announced a similar research milestone with the FDA approval of the TriClip system for tricuspid regurgitation. We celebrated this important milestone with local media KSTP-TV, who spotlighted the importance of this new technology. We were proud to be a leading clinical site led by Global PI Dr. Paul Sorajja and the MHIF research team who contributed significant data to the pivotal trial.